Rezolute (RZLT) Total Liabilities (2011 - 2026)
Rezolute (RZLT) posted Total Liabilities of $8.6 million for Q1 2026, down 18.87% sequentially from $10.6 million in Q4 2025, and down 29.33% YoY from $12.2 million in Q1 2025.
Rezolute (RZLT) Total Liabilities (2011 - 2026) Analysis & Trends
Rezolute has reported Total Liabilities for 16 years, with the latest figure at $8.6 million in Q1 2026.
- Quarterly Total Liabilities fell 29.33% year-over-year to $8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (down 29.33% YoY) and the FY2025 annual result came in at $13.4 million, up 13.88% from the prior year.
- Total Liabilities eased to $8.6 million in Q1 2026 per RZLT's latest filing, from $10.6 million in the prior quarter.
- Over five years, Total Liabilities peaked at $17.7 million in Q1 2022 and troughed at $2.9 million in Q3 2022.
- A 5-year average of $10.2 million and a median of $10.4 million in 2023 frame the typical range for Total Liabilities.
- The widest YoY moves for Total Liabilities: up 364.77% in 2022, down 83.15% in 2022.
- Over 5 years, Total Liabilities stood at $8.9 million in 2022, then rose by 16.54% to $10.4 million in 2023, then gained by 19.15% to $12.4 million in 2024, then dropped by 14.64% to $10.6 million in 2025, then retreated by 18.87% to $8.6 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $8.6 million, $10.6 million, and $11.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - | 8.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.60 Mn |
| Dec 31, 2025 | 10.60 Mn |
| Sep 30, 2025 | 11.50 Mn |
| Jun 30, 2025 | 13.36 Mn |
| Mar 31, 2025 | 12.17 Mn |
| Dec 31, 2024 | 12.42 Mn |
| Sep 30, 2024 | 9.97 Mn |
| Jun 30, 2024 | 11.73 Mn |
| Mar 31, 2024 | 16.88 Mn |
| Dec 31, 2023 | 10.42 Mn |
| Sep 30, 2023 | 9.44 Mn |
| Jun 30, 2023 | 7.55 Mn |
| Mar 31, 2023 | 6.90 Mn |
| Dec 31, 2022 | 8.94 Mn |
| Sep 30, 2022 | 2.90 Mn |
| Jun 30, 2022 | 2.95 Mn |
| Mar 31, 2022 | 17.67 Mn |
| Dec 31, 2021 | 21.14 Mn |
| Sep 30, 2021 | 17.20 Mn |
| Jun 30, 2021 | 16.51 Mn |